PROTAC MLKL Degrader-2
Product Specifications
Target
PROTACs|||MLK
Related Pathways
PROTAC|||MAPK
Bioactivity
PROTAC MLKL Degrader-2, a PROTAC that targets MLKL (Mixed Lineage Kinase), incorporates the PROTAC target protein ligand, E3 ligase ligand Thalidomide, and PROTAC Linker N-Methylpiperazine. The conjugate of the E3 ubiquitin ligase ligand and Linker is Thalidomide-N-Methylpiperazine. This compound exhibits antinecroptotic activity in human cell lines and effectively degrades MLKL in the HT-29 xenograft mouse model.
Molecular Formula
C36H35N9O9S
Molecular Weight
769.78
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/240554467194306576/T200218
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1146485-01 0.02 mg (E-Coli)
Recombinant Burkholderia cepacia Phosphoserine aminotransferase (serC)
Ask
View Details MBS1146485-02 0.02 mg (Yeast)
Recombinant Burkholderia cepacia Phosphoserine aminotransferase (serC)
Ask
View Details MBS1146485-03 0.1 mg (E-Coli)
Recombinant Burkholderia cepacia Phosphoserine aminotransferase (serC)
Ask
View Details MBS1146485-04 0.1 mg (Yeast)
Recombinant Burkholderia cepacia Phosphoserine aminotransferase (serC)
Ask
View Details MBS1146485-05 0.02 mg (Baculovirus)
Recombinant Burkholderia cepacia Phosphoserine aminotransferase (serC)
Ask
View Details